oxazolidin-2-one has been researched along with Klebsiella Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aslanidis, T; Giannakou-Peftoulidou, M; Myrou, A | 1 |
George, D; Gibson, G; Hardink, J; Lamb, L; Marra, A; Medina, I; O'Donnell, JP; Rugg, J; Van Deusen, J | 1 |
2 other study(ies) available for oxazolidin-2-one and Klebsiella Infections
Article | Year |
---|---|
Management of a young female patient with Fournier's gangrene and Lemierre's syndrome.
Topics: Acetamides; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Debridement; Drug Therapy, Combination; Echinocandins; Female; Fournier Gangrene; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lemierre Syndrome; Linezolid; Lipopeptides; Oxazolidinones; Staphylococcal Infections; Staphylococcus epidermidis; Young Adult | 2014 |
Effect of linezolid on the 50% lethal dose and 50% protective dose in treatment of infections by Gram-negative pathogens in naive and immunosuppressed mice and on the efficacy of ciprofloxacin in an acute murine model of septicemia.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Administration Routes; Drug Administration Schedule; Drug Interactions; Female; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Lethal Dose 50; Linezolid; Mice; Models, Animal; Oxazolidinones; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Survival Rate; Treatment Outcome | 2012 |